Baseline characteristics of participants in the OGTT
| Noncarriers | Carriers | P | |
|---|---|---|---|
| n | 14 | 15 | |
| Age (years) | 52 ± 9 | 55 ± 13 | 0.51 |
| Men | 7 (50) | 9 (60) | 0.59 |
| BMI | 24.9 ± 2.9 | 24.7 ± 2.8 | 0.89 |
| Cholesterol (mmol/l) | |||
| Total | 4.99 ± 1.20 | 4.50 ± 0.92 | 0.23 |
| LDL | 3.09 ± 0.97 | 3.22 ± 0.83 | 0.71 |
| HDL | 1.57 ± 0.40 | 0.70 ± 0.30 | <0.001 |
| Triglycerides (mmol/l) | 0.68 [0.44–0.92] | 0.75 [0.53–2.14] | 0.17 |
| Fasting glucose (mmol/l) | 5.2 ± 0.5 | 5.1 ± 1.2 | 0.76 |
| Fasting insulin (pmol/l) | 43 ± 20 | 48 ± 35 | 0.62 |
| HOMA index | 1.44 ± 0.71 | 1.65 ± 1.30 | 0.60 |
| History of CAD | 0 (0) | 3 (20) | 0.08 |
| History of diabetes | 0 (0) | 0 (0) | N/A |
| Family history of diabetes | 1 (7) | 0 (0) | 0.29 |
| Smokers | 2 (14) | 2 (13) | 0.94 |
| Medication use | |||
| Statins | 1 (7) | 5 (33) | 0.08 |
| Hormone replacement therapy | 1 (7) | 0 (0) | 0.29 |
| Thiazides | 0 (0) | 0 (0) | N/A |
| β-Blockers | 1 (7) | 1 (7) | 0.96 |
Data are means ± SD, n (%), or median [IQR].